Company Overview
NEKTAR THERAPEUTICS
NKTRRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
55M
2025 FY
Net Income
-164M
2025 FY
Shares Outstanding
17M
2025 FY
EPS
-9.73USD
2025 FY
Company Information
SIC Code
2834
CIK Code
906709
Exchange
Nasdaq
Location
US